Product Information
POSACONAZOLE DR 100 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $2.0315 per EA under NDC 62135042960. Its NADAC has been published 187 times since Mar 8, 2023.
FDA first approved this application on Aug 21, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Chartwell RX LLCNDC
62135042960
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POSACONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA212411FDA Approved
8/21/2019
TE Code
AB
On Market Since
8/28/2019
Pharmacological Classes
Price Statistics
The NADAC for POSACONAZOLE DR 100 MG TABLET has been published 187 times since Mar 8, 2023, and over the history we have for it it has declined 78.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0315 per EA |
|---|---|
| All-time high | $9.6049 (Mar 15, 2023) |
| All-time low | $1.9969 (Aug 19, 2026) |
| 52-week high | $3.7685 |
| 52-week low | $1.9969 |
| Median price | $4.2030 |
| Average price | $4.7806 |
| Largest weekly change | +38.6% (Oct 18, 2023) |
| Weeks tracked | 187 |
| Tracking since | Mar 8, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Posaconazole Delayed-Release market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Posaconazole Delayed-Release market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POSACONAZOLE DR 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POSACONAZOLE DR 100 MG TABLET, manufactured by Chartwell RX LLC, is $2.0315 per EA (NDC 62135042960), effective Sep 30, 2026.
How has the price of POSACONAZOLE DR 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for POSACONAZOLE DR 100 MG TABLET has declined 78.8%. It has been tracked across 187 weekly CMS publications since Mar 8, 2023.
What are the highest and lowest recorded NADAC prices for POSACONAZOLE DR 100 MG TABLET?
Since Mar 8, 2023, the NADAC for POSACONAZOLE DR 100 MG TABLET has ranged from a low of $1.9969 (Aug 19, 2026) to a high of $9.6049 (Mar 15, 2023), with a median of $4.2030 per EA.
Are there cheaper alternatives to POSACONAZOLE DR 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of POSACONAZOLE DR 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POSACONAZOLE DR 100 MG TABLET?
POSACONAZOLE DR 100 MG TABLET (NDC 62135042960) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.